CLINICAL OUTCOMES OF CHILDREN WITH CYSTIC FIBROSIS TREATED WITH INTRAVENOUS TOBRAMYCIN BASED ON A PHARMACOKINETIC ASSESMENT

被引：0
|
作者：
Abrahamsen, K. [1 ,2 ]
Nielsen, K. G. [3 ]
Petersen, K. L. [4 ]
Milla, C. E. [1 ]
机构：
[1] Stanford Univ, Sch Med, Dept Pediat, Ctr Excellence Pulm Biol, Palo Alto, CA 94304 USA
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Rigshosp, Dept Pediat & Adolescent Med, DK-2100 Copenhagen, Denmark
[4] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA
来源：
PEDIATRIC PULMONOLOGY | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
222
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [31] Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation * Ototoxicity following tobramycin treatment
    Harruff, E. Emily
    Kil, Jonathan
    Ortiz, Maria Gabriela Tupayachi
    Dorgan, Daniel
    Jain, Raksha
    Poth, Elizabeth A.
    Fifer, Robert C.
    Kim, Yun Jin M.
    Shoup, Angela G.
    Flume, Patrick A.
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (02) : 288 - 294
  • [32] COMPARISON OF DRUG COSTS & CLINICAL OUTCOMES WITH TOBRAMYCIN SOLUTION FOR INHALATION & AZTREONAM LYSINE FOR INHALATION IN CYSTIC FIBROSIS
    Signorovitch, J.
    Latremouille-Viau, D.
    Dea, K.
    Wu, E.
    Zhang, J.
    PEDIATRIC PULMONOLOGY, 2010, : 309 - 309
  • [33] New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic Analysis
    Koloskoff, Kevin
    Thirion, Daniel J. G.
    Matouk, Elias
    Marsot, Amelie
    THERAPEUTIC DRUG MONITORING, 2023, 45 (02) : 251 - 258
  • [34] Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis
    Gibson, RL
    Emerson, J
    McNamara, S
    Burns, LL
    Rosenfeld, M
    Yunker, A
    Hamblett, N
    Accurso, F
    Dovey, M
    Hiatt, P
    Konstan, MW
    Moss, R
    Retsch-Bogart, G
    Wagener, J
    Waltz, D
    Wilmott, R
    Zeitlin, PL
    Ramsey, B
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) : 841 - 849
  • [35] Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis
    Stanojevic, Sanja
    Waters, Valerie
    Mathew, Joseph L.
    Taylor, Louise
    Ratjen, Felix
    JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (02) : 172 - 178
  • [36] Area under the curve achievement of once daily tobramycin in children with cystic fibrosis during clinical care
    Brockmeyer, Jake M.
    Wise, Russell T.
    Burgener, Elizabeth B.
    Milla, Carlos
    Frymoyer, Adam
    PEDIATRIC PULMONOLOGY, 2020, 55 (12) : 3343 - 3350
  • [37] Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis
    Hoppe, Jordana E.
    Wagner, Brandie D.
    Accurso, Frank J.
    Zemanick, Edith T.
    Sagel, Scott D.
    JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (06) : 760 - 768
  • [38] The pharmacokinetic of the main oral antibiotics in children with cystic fibrosis
    Kondakova, Yulia
    Kondratyeva, Elena
    Zyryanov, Sergey
    Bondareva, Irina
    Sherman, Victoria
    Melyanovskaya, Yuliya
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [39] PHARMACOKINETIC EVALUATION OF CEFSULODIN IN CHILDREN WITH AND WITHOUT CYSTIC-FIBROSIS TREATED FOR INFECTIOUS-DISEASES
    MICHALSEN, H
    BERGAN, T
    SOLBERG, R
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1986, 8 (11): : 685 - 687
  • [40] Outcomes of fundoplication in children with cystic fibrosis
    Boesch, R. Pau
    Acton, James D.
    JOURNAL OF PEDIATRIC SURGERY, 2007, 42 (08) : 1341 - 1344
12345